| Original language | English |
|---|---|
| Pages (from-to) | 314-315 |
| Number of pages | 2 |
| Journal | World Psychiatry |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2022 |
Repurposing fluvoxamine, and other psychiatric medications, for COVID-19 and other conditions
- Eric J. Lenze
- , Angela M. Reiersen
- , Paramala J. Santosh
- School of Medicine
- Department of Psychiatry
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Hope Center for Neurological Disorders
- COVID-19 Researchers
- Division of Child & Adolescent Psychiatry
- Intellectual and Developmental Disabilities Research Center (IDDRC)
Research output: Contribution to journal › Letter › peer-review
11
Scopus
citations